U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172243) titled 'BE.Amycon Biobank & Data Registry UZ Leuven' on Aug. 20.
Brief Summary: The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Amyloidosis
AL Amyloidosis
Amyloidosis Cardiac
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Universitaire Ziekenhuizen KU Leuven
Published by HT Digital Content Services with permission from Health Daily Digest....